Clinical Development

Level 2

  • 1

    Module 1: Early phase volunteer studies

    • Module 1
  • 2

    Module 2: Efficacy Trials: Phase II, Proof of Concept and Phase III

    • slide 2

    • slide 3

    • slide 4_1

    • slide 5

    • slide 6_1

    • slide 7

    • slide 8_1

    • Knowledge Checkpoints 01

    • slide 9_1

    • slide 10

    • slide 11_1

    • slide 12

    • Knowledge Checkpoints 02

    • slide 13
  • 3

    Module 3: Phases of Clinical Trials: Phase IV and Real- World Evidence

    • slide 2

    • slide 3

    • slide 4_1

    • slide 5

    • slide 6_1

    • slide 7_1

    • slide 8_1

    • slide 9_1

    • Knowledge Checkpoints 01

    • slide 10_1

    • slide 11_1

    • slide 12

    • slide 13

    • Knowledge Checkpoints 02

    • slide 14_2

    • slide 15_1

    • Knowledge Checkpoints 03

    • slide 16
  • 4

    Module 4: RWE and how it is used

    • Module 4

Instructor

Chief Operating Officer

Dr Tina Barton

Dr. Tina Barton, Chief Operating Officer of eMQT, is a drug development specialist with over 40 years’ experience, working in partnership to lead for success as a customer-focused senior leader. During this time Dr. Barton has invested in training for the future – through team leadership, individual mentoring and training thereby sharing knowledge and developing professionals. Through her role at the Institute of Clinical Research she continues to support and lead training activities. With a passion for transformation, Dr. Barton drove the embracement of Central Eastern European countries and now is focused on the inclusion of Sub-Saharan Africa into clinical development – bringing the miracle of development of new medicines to emerging markets and new patients. Dr. Barton holds a BSc, PhD and MBA alongside over 50 academic publications and is an Honorary Fellow, and Board Member of the Institute of Clinical Research.